Yarrow Bioscience Inc
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (6)
Yarrow Bioscience Inc owes $0.07 for every $1 it owns.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/B ratio
8.27The share price is 8.27 times Yarrow Bioscience Inc's book value per share, higher than 83% of Healthcare companies in United States.
Market cap
$182 MThe total market value of all of Yarrow Bioscience Inc's shares at today's price (share price × number of shares), smaller than 59% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$22 MWhat Yarrow Bioscience Inc would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$2.37Net worth divided by the number of shares. The share price of $19.60 is 8.3 times this, which is the P/B above.
Owes vs Owns
0.07×Yarrow Bioscience Inc owes $0.07 for every $1 it owns (low), lower than 93% of Healthcare companies in United States.
Dividend yield
NoneYarrow Bioscience Inc does not currently pay a dividend.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Yarrow Bioscience Inc: $182 M ÷ $22 M (30 Jun 2026) = 8.3.
How much does Yarrow Bioscience Inc owe compared with what it owns?
Yarrow Bioscience Inc owes $0.07 for every $1 it owns (low), lower than 93% of Healthcare companies in United States.
Does Yarrow Bioscience Inc pay a dividend?
No. Yarrow Bioscience Inc does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.